Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon-alpha: an efficacious immune-modulating therapy for ulcerative colitis?

F Baert1, P Rutgeerts

  • 1Inflammatory Bowel Disease Research Unit, University Hospital, Leuven, Belgium.

European Journal of Gastroenterology & Hepatology
|July 1, 1995
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-stakeholder Delphi consensus on future care for inflammatory bowel disease in Belgium.

Acta gastro-enterologica Belgica·2026
Same author

Real-world Effectiveness and Safety of Tofacitinib in Multi-Refractory Ulcerative Colitis: insights from a Belgian Cohort with prior Anti-TNF and Vedolizumab Exposure.

Acta gastro-enterologica Belgica·2025
Same author

Assessing Child Pain-Related Injustice Appraisals: A Discriminant Content Analysis Study.

European journal of pain (London, England)·2025
Same author

Switching intravenous to subcutaneous infliximab was safe and successful during 1-year follow up in Ulcerative Colitis and Crohn patients - a Belgian single center experience.

Acta gastro-enterologica Belgica·2025
Same author

Quality outcome measures project in IBD: a proof-of-concept benchmarking study in three Belgian IBD units.

Acta gastro-enterologica Belgica·2024
Same author

Ulcerative colitis treatment : an insight into daily clinical practice.

Acta gastro-enterologica Belgica·2019